19-7261430-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000208.4(INSR):​c.652+5915A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.482 in 152,058 control chromosomes in the GnomAD database, including 19,762 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.48 ( 19762 hom., cov: 32)

Consequence

INSR
NM_000208.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.613

Publications

16 publications found
Variant links:
Genes affected
INSR (HGNC:6091): (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
INSR Gene-Disease associations (from GenCC):
  • insulin-resistance syndrome type A
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
  • Donohue syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • hyperinsulinism due to INSR deficiency
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Ambry Genetics
  • Rabson-Mendenhall syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.732 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000208.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INSR
NM_000208.4
MANE Select
c.652+5915A>G
intron
N/ANP_000199.2
INSR
NM_001079817.3
c.652+5915A>G
intron
N/ANP_001073285.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INSR
ENST00000302850.10
TSL:1 MANE Select
c.652+5915A>G
intron
N/AENSP00000303830.4
INSR
ENST00000341500.9
TSL:1
c.652+5915A>G
intron
N/AENSP00000342838.4
INSR
ENST00000598216.1
TSL:1
n.627+5915A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.482
AC:
73181
AN:
151940
Hom.:
19723
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.739
Gnomad AMI
AF:
0.350
Gnomad AMR
AF:
0.403
Gnomad ASJ
AF:
0.496
Gnomad EAS
AF:
0.232
Gnomad SAS
AF:
0.319
Gnomad FIN
AF:
0.295
Gnomad MID
AF:
0.544
Gnomad NFE
AF:
0.403
Gnomad OTH
AF:
0.488
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.482
AC:
73254
AN:
152058
Hom.:
19762
Cov.:
32
AF XY:
0.471
AC XY:
35039
AN XY:
74316
show subpopulations
African (AFR)
AF:
0.739
AC:
30650
AN:
41466
American (AMR)
AF:
0.402
AC:
6133
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.496
AC:
1720
AN:
3470
East Asian (EAS)
AF:
0.232
AC:
1202
AN:
5174
South Asian (SAS)
AF:
0.319
AC:
1541
AN:
4824
European-Finnish (FIN)
AF:
0.295
AC:
3121
AN:
10562
Middle Eastern (MID)
AF:
0.551
AC:
162
AN:
294
European-Non Finnish (NFE)
AF:
0.403
AC:
27393
AN:
67988
Other (OTH)
AF:
0.481
AC:
1013
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1737
3474
5212
6949
8686
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
620
1240
1860
2480
3100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.431
Hom.:
24260
Bravo
AF:
0.503
Asia WGS
AF:
0.299
AC:
1042
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
0.88
DANN
Benign
0.40
PhyloP100
-0.61
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs919275; hg19: chr19-7261441; API